Rabies virus-based COVID-19 vaccine CORAVAX™ induces high levels of neutralizing antibodies against SARS-CoV-2

The recently emerged coronavirus SARS-CoV-2, the causative agent of COVID-19, is rapidly spreading in the world. The exponentially expanding threat of SARS-CoV-2 to global health highlights the urgent need for a vaccine. Herein we show the rapid development of a novel, highly efficient, and safe COV...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurup, Drishya, Wirblich, Christoph, Ramage, Holly, Schnell, Matthias J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568577/
https://www.ncbi.nlm.nih.gov/pubmed/33088593
http://dx.doi.org/10.1038/s41541-020-00248-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568577/
https://www.ncbi.nlm.nih.gov/pubmed/33088593
http://dx.doi.org/10.1038/s41541-020-00248-6

Ejemplares similares